A carregar...

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

BACKGROUND: The novel iron-based phosphate binder sucroferric oxyhydroxide is being investigated for the treatment of hyperphosphatemia. Patients with chronic kidney disease often have multiple comorbidities that may necessitate the daily use of several types of medication. Therefore, the potential...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nephrol
Main Authors: Chong, Edward, Kalia, Veena, Willsie, Sandra, Winkle, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4242982/
https://ncbi.nlm.nih.gov/pubmed/24699894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-014-0080-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!